GMI

Swine Flu Research







The outbreak strain has been identified as a swine-origin influenza virus that resulted from a reassortment of two previously circulating strains: a “triple-reassortant” swine influenza that has been circulating in North America since 1998 and an H1N1 strain that has been circulating for decades in swine populations in Europe and Asia. The new strain contains six segments from the North American lineage and two segments from the Eurasian lineage [1]. 

 

According to Dr. Adrian Gibbs, the prominent virologists who worked with the Swiss drug maker Roche to develop the anti-influenza drug oseltamivir (Tamiflu), the Swine Flu is Man-Made.  In a Bloomberg News interview from May 13, 2009, Dr. Adrian Gibbs described the vast improbability of a virus self-assembling out of DNA sequences from four distinct species, without adequate evolutionary time to do so.